Nutex Health (NUTX) Stock Forecast, Price Target & Predictions
NUTX Stock Forecast
Nutex Health stock forecast is as follows: an average price target of $45.00 (represents a 41.11% upside from NUTX’s last price of $31.89) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
NUTX Price Target
The average price target for Nutex Health (NUTX) is $45.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $45.00 to $45.00. This represents a potential 41.11% upside from NUTX's last price of $31.89.
NUTX Analyst Ratings
According to 2 Wall Street analysts, Nutex Health's rating consensus is 'Buy'. The analyst rating breakdown for NUTX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Nutex Health Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 18, 2024 | Anthony Vendetti | Maxim Group | - | - | 80.72% | 41.11% |
The latest Nutex Health stock forecast, released on Sep 18, 2024 by Anthony Vendetti from Maxim Group, set a price target of $45.00, which represents a 80.72% increase from the stock price at the time of the forecast ($24.90), and a 41.11% increase from NUTX last price ($31.89).
Nutex Health Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $45.00 | $45.00 |
| Last Closing Price | $31.89 | $31.89 | $31.89 |
| Upside/Downside | -100.00% | 41.11% | 41.11% |
In the current month, the average price target of Nutex Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Nutex Health's last price of $31.89. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 18, 2024 | Maxim Group | Buy | Initialise | |
| Aug 21, 2024 | Benchmark | Buy | Buy | Hold |
| May 15, 2024 | Benchmark | Buy | Buy | Hold |
| Dec 23, 2022 | Benchmark | Buy | Initialise |
Nutex Health's last stock rating was published by Maxim Group on Sep 18, 2024. The company Initialise its NUTX rating from "null" to "Buy".
Nutex Health Financial Forecast
Nutex Health Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $69.67M | $62.72B | $58.92M | $56.33M | $53.72M |
| Avg Forecast | $94.51M | $88.80M | $85.88M | $83.07M | $81.02M | $73.22M | $68.20M | $64.80M | $69.70M | $63.00M | $62.05M | $56.05M | $49.95M |
| High Forecast | $95.52M | $89.74M | $86.79M | $83.30M | $82.54M | $73.94M | $68.93M | $65.49M | $70.45M | $63.67M | $62.71M | $56.65M | $50.48M |
| Low Forecast | $93.50M | $87.85M | $84.96M | $82.83M | $79.50M | $72.51M | $67.47M | $64.11M | $68.95M | $62.33M | $61.39M | $55.45M | $49.42M |
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | 1.00% | 995.60% | 0.95% | 1.00% | 1.08% |
Nutex Health's average Quarter revenue forecast for Mar 24 based on 1 analysts is $64.80M, with a low forecast of $64.11M, and a high forecast of $65.49M. NUTX's average Quarter revenue forecast represents a -6.99% decrease compared to the company's last Quarter revenue of $69.67M (Dec 23).
Nutex Health EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | $-25.70M | $2.96B | $3.93M | $-698.79K | $-5.99M |
| Avg Forecast | $-11.24M | $-10.56M | $-10.22M | $-9.88M | $-9.64M | $-8.71M | $-8.11M | $-7.71M | $-8.29M | $-7.49M | $-7.38M | $-6.67M | $-5.94M |
| High Forecast | $-11.12M | $-10.45M | $-10.11M | $-9.85M | $-9.46M | $-8.63M | $-8.03M | $-7.63M | $-8.20M | $-7.41M | $-7.30M | $-6.60M | $-5.88M |
| Low Forecast | $-11.36M | $-10.68M | $-10.32M | $-9.91M | $-9.82M | $-8.80M | $-8.20M | $-7.79M | $-8.38M | $-7.57M | $-7.46M | $-6.74M | $-6.01M |
| Surprise % | - | - | - | - | - | - | - | - | 3.10% | -394.89% | -0.53% | 0.10% | 1.01% |
1 analysts predict NUTX's average Quarter EBITDA for Dec 23 to be $-8.29M, with a high of $-8.20M and a low of $-8.38M. This is -100.28% lower than Nutex Health's previous annual EBITDA (Sep 23) of $2.96B.
Nutex Health Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | $-31.62M | $-5.54B | $-3.48M | $-6.92M | $-10.66M |
| Avg Forecast | $3.11M | $3.85M | $2.75M | $-816.00K | $-1.07M | $-1.22M | $-1.48M | $8.04M | $10.65M | $-3.83M | $-3.83M | $-11.48M | $-11.48M |
| High Forecast | $3.15M | $3.90M | $2.79M | $-765.00K | $-1.06M | $-1.21M | $-1.46M | $8.15M | $10.80M | $-3.77M | $-3.77M | $-11.32M | $-11.32M |
| Low Forecast | $3.07M | $3.80M | $2.72M | $-867.00K | $-1.09M | $-1.24M | $-1.50M | $7.93M | $10.50M | $-3.88M | $-3.88M | $-11.63M | $-11.63M |
| Surprise % | - | - | - | - | - | - | - | - | -2.97% | 1448.98% | 0.91% | 0.60% | 0.93% |
Nutex Health's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. NUTX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Nutex Health SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | $8.50M | $7.79B | $10.01M | $9.08M | $6.31M |
| Avg Forecast | $24.24M | $22.77M | $22.02M | $21.30M | $20.78M | $18.78M | $17.49M | $16.62M | $17.87M | $16.16M | $15.91M | $14.37M | $12.81M |
| High Forecast | $24.50M | $23.01M | $22.26M | $21.36M | $21.17M | $18.96M | $17.68M | $16.80M | $18.07M | $16.33M | $16.08M | $14.53M | $12.95M |
| Low Forecast | $23.98M | $22.53M | $21.79M | $21.24M | $20.39M | $18.60M | $17.30M | $16.44M | $17.68M | $15.98M | $15.74M | $14.22M | $12.67M |
| Surprise % | - | - | - | - | - | - | - | - | 0.48% | 482.47% | 0.63% | 0.63% | 0.49% |
Nutex Health's average Quarter SG&A projection for Mar 24 is $16.62M, based on 1 Wall Street analysts, with a range of $16.44M to $16.80M. The forecast indicates a 95.51% rise compared to NUTX last annual SG&A of $8.50M (Dec 23).
Nutex Health EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | $-0.05 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Avg Forecast | $0.61 | $0.76 | $0.54 | $-0.16 | $-0.21 | $-0.24 | $-0.29 | $1.58 | $2.09 | $-0.75 | $-0.75 | $-2.25 | $-2.25 |
| High Forecast | $0.62 | $0.77 | $0.55 | $-0.15 | $-0.21 | $-0.24 | $-0.29 | $1.60 | $2.12 | $-0.74 | $-0.74 | $-2.22 | $-2.22 |
| Low Forecast | $0.60 | $0.74 | $0.53 | $-0.17 | $-0.21 | $-0.24 | $-0.29 | $1.55 | $2.06 | $-0.76 | $-0.76 | $-2.28 | $-2.28 |
| Surprise % | - | - | - | - | - | - | - | - | -0.02% | 0.01% | 0.01% | 0.00% | 0.01% |
According to undefined Wall Street analysts, Nutex Health's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to NUTX previous annual EPS of $NaN (undefined).
Nutex Health Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HLTH | Cue Health | - | - | 19900.00% | Hold |
| BEAT | HeartBeam | - | - | 253.36% | Buy |
| EVH | Evolent Health | - | - | 252.55% | Buy |
| HCTI | Healthcare Triangle | - | - | 86.92% | Buy |
| PRVA | Privia Health Group | - | - | 60.44% | Buy |
| NUTX | Nutex Health | - | - | 41.11% | Buy |
| UTRS | Minerva Surgical | - | - | - | Buy |
| HSTM | HealthStream | - | - | -8.86% | Buy |